Rhone-Poulenc was a French multinational pharmaceutical and chemical company formed in 1998 through the merger of Rhone-Poulenc S.A. and Hoechst AG. It specialized in the production of pharmaceuticals, agrochemicals, and biotechnology products, contributing significantly to advancements in health and agriculture. In 2004, Rhone-Poulenc became part of Sanofi-Aventis after a merger, further expanding its reach in the global pharmaceutical market. The company was known for its research and development efforts, particularly in areas like cardiovascular health, oncology, and vaccines, playing a vital role in improving public health worldwide.